Related Experiment Video
Updated: Aug 6, 2026

07:57
Necropsy-based Wild Fish Health Assessment
Published on: September 11, 2018
A National Epidemiological Study of Inherited Ichthyoses in England from 1998-2024
Mark D Eisner1,2,3, Maisie Blyth3, Jennifer M Broughan3
1Translational Clinical Research Institute, Newcastle University, Newcastle, UK.
The British Journal of Dermatology
|July 21, 2026
Summary
Epidemiological data reveal rare ichthyoses patients have increased comorbidities and mortality. Genetic testing is underutilized, highlighting a need for improved healthcare planning and research for these rare skin conditions.
Area of Science:
- Dermatology and Genetic Medicine
- Public Health and Epidemiology
- Rare Diseases Research
Background:
- Ichthyoses are a group of genetic skin disorders associated with significant morbidity and mortality.
- Existing epidemiological data lack comprehensive linkage between ichthyosis diagnoses and systemic comorbidities.
- Understanding the national burden of ichthyoses is crucial for effective healthcare provision and research.
Purpose of the Study:
- To present epidemiological data on inherited ichthyoses in England.
- To detail patient-level comorbidities and genetic testing status within this cohort.
- To establish a baseline for future research and healthcare planning.
Main Methods:
- A national retrospective cohort study utilizing English healthcare databases (1998-2024).
- Identification of ichthyosis cases via ICD-10 codes.
- Extraction of demographic, comorbidity, genetic testing, and mortality data from routine NHS records.
Main Results:
- Identified 4330 ichthyosis patients, with 3758 classified as rare ichthyoses (prevalence 51.6/million).
- Rare ichthyoses cohort showed increased prevalence of asthma, inflammatory arthropathies, and atrial fibrillation compared to the general population.
- Significantly higher mortality before age 25 (18.5%) and lower rates of genetic testing (56% of tested cases had identified pathogenic variants).
Conclusions:
- Patients with rare ichthyoses experience a broader spectrum of comorbidities, indicating a substantial systemic burden.
- The findings underscore the need for improved healthcare planning and research design.
- Data highlight inequities in care and the importance of genetic testing for diagnosis and management.